Education
About Us
Working with TipRanks
Follow Us
Protalix Biotherapeutics (PLX)
:PLX
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 52.74M | $ 53.40M | $ 65.49M | $ 47.64M | $ 38.35M |
| Gross Profit | $ 25.75M | $ 29.08M | $ 42.51M | $ 28.05M | $ 22.00M |
| Operating Income | $ -5.50M | $ 3.92M | $ 10.46M | $ -13.01M | $ -20.46M |
| EBITDA | $ -5.50M | $ 6.52M | $ 12.94M | $ -10.78M | $ -18.94M |
| Net Income | $ -6.60M | $ 2.93M | $ 8.31M | $ -14.93M | $ -27.58M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 14.68M | $ 34.83M | $ 44.56M | $ 22.18M | $ 38.98M |
| Total Assets | $ 82.35M | $ 73.42M | $ 84.43M | $ 55.79M | $ 73.67M |
| Total Debt | $ 8.32M | $ 5.53M | $ 27.69M | $ 33.47M | $ 33.47M |
| Net Debt | $ -6.36M | $ -14.23M | $ 4.06M | $ 16.36M | $ -5.51M |
| Total Liabilities | $ 34.12M | $ 30.21M | $ 50.87M | $ 66.43M | $ 79.70M |
| Stockholders' Equity | $ 48.23M | $ 43.21M | $ 33.57M | $ -10.64M | $ -6.04M |
| Cash Flow | |||||
| Free Cash Flow | $ -11.99M | $ 7.39M | $ -2.47M | $ -25.63M | $ -11.74M |
| Operating Cash Flow | $ -11.99M | $ 8.67M | $ -1.32M | $ -25.00M | $ -10.29M |
| Investing Cash Flow | $ -2.37M | $ 4.22M | $ -16.71M | $ -5.04M | $ 18.92M |
| Financing Cash Flow | $ 9.33M | $ -16.79M | $ 24.67M | $ 8.24M | $ 12.08M |